(Q33948693)

30 July 2017

2 references

17 September 2019

25 January 2021

Vinorelbine--a clinical review (English)

1 reference

30 July 2017

main subject

heterocyclic compound

1 reference

phytogenic antineoplastic agents

17 September 2019

1 reference

25 January 2021

Gregory RK

1

1 reference

30 July 2017

Smith IE

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

3 references

British Journal of Cancer

30 July 2017

17 September 2019

25 January 2021

3 references

30 July 2017

17 September 2019

25 January 2021

82

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

1907-1913

1 reference

The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOI

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Vinorelbine Chemotherapy in Non Small Cell Lung Cancer: Experience in Elderly Patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Cisplatin and Vinorelbine Followed by Radiotherapy in the Treatment of Stage III-B Non-Small-Cell Lung Cancer Patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Inactivation of Bcl-2 by phosphorylation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Microtubule Formation in vitro in Solutions Containing Low Calcium Concentrations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Myocardial infarction and vinorelbine. Report of a case

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Pharmacokinetics of vinorelbine in man.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Clinical pharmacokinetics of vinorelbine alone and combined with cisplatin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

The Current and Future Place of Vinorelbine in Cancer Therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Systemic Therapy of Advanced Breast Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Phase-II study of Navelbine in advanced breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363259

Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography

29 October 2018

1 reference

12 December 2020

Navelbine: an ultrastructural study of its effects

1 reference

12 December 2020

Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine)

1 reference

12 December 2020

Experimental antitumor activity of Navelbine

1 reference

12 December 2020

High-performance liquid chromatographic determination of navelbine in MO4 mouse fibrosarcoma cells and biological fluids

1 reference

12 December 2020

Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography

1 reference

12 December 2020

[Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog]

1 reference

12 December 2020

Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer

1 reference

12 December 2020

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

1 reference

12 December 2020

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

12 December 2020

Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs

1 reference

12 December 2020

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

12 December 2020

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

12 December 2020

Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience

1 reference

12 December 2020

Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II study

1 reference

12 December 2020

Does induction chemotherapy with a mitoxantrone/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer? A French Northern Oncology Group trial in 105 patients. French Northern Oncology Group

1 reference

12 December 2020

Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients

1 reference

12 December 2020

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method

1 reference

12 December 2020

Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study

1 reference

12 December 2020

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study

1 reference

12 December 2020

Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix

1 reference

12 December 2020

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Safety and tolerance of Navelbine in phase I-II clinical studies

1 reference

12 December 2020

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence

1 reference

12 December 2020

Determination of navelbine and desacetylnavelbine in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules

1 reference

12 December 2020

Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1203

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference